Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Provenzano

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Cell Death & Disease|January 23, 2015
The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscapeA Modelska, E Turro, R Russell, et al.
British Journal of Cancer|January 10, 2013
A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trialE Provenzano, A-L Vallier, R Champ, et al.
British Journal of Cancer|January 19, 2013
Astronomical algorithms for automated analysis of tissue protein expression in breast cancerH R Ali, M Irwin, L Morris, et al.
NPJ Breast Cancer|March 14, 2018
Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohortA Mukherjee, R Russell, Suet-Feung Chin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 19, 2024
Neoadjuvant Radiotherapy and Endocrine Therapy for Oestrogen Receptor Positive Breast Cancers: The Neo-RT Feasibility StudyS V Lightowlers, A Machin, R Woitek, et al.
European Radiology|September 18, 2008
Use of ultrasound-guided axillary node core biopsy in staging of early breast cancerP D Britton, A Goud, S Godward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2015
PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytesH R Ali, S-E Glont, F M Blows, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 12, 2025
Discrepancy between mammographic and pathological sizing of screen-detected DCIS: Risk factors and impact on ipsilateral recurrence ratesC C Kirwan, B Hilton, K Clements, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2015
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaborationV Bossuyt, E Provenzano, W F Symmans, et al.
British Journal of Cancer|July 29, 2010
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy receivedS-J Dawson, N Makretsov, F M Blows, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cell Death & Disease|January 23, 2015
The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscapeA Modelska, E Turro, R Russell, et al.
British Journal of Cancer|January 10, 2013
A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trialE Provenzano, A-L Vallier, R Champ, et al.
British Journal of Cancer|January 19, 2013
Astronomical algorithms for automated analysis of tissue protein expression in breast cancerH R Ali, M Irwin, L Morris, et al.
NPJ Breast Cancer|March 14, 2018
Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohortA Mukherjee, R Russell, Suet-Feung Chin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 19, 2024
Neoadjuvant Radiotherapy and Endocrine Therapy for Oestrogen Receptor Positive Breast Cancers: The Neo-RT Feasibility StudyS V Lightowlers, A Machin, R Woitek, et al.
European Radiology|September 18, 2008
Use of ultrasound-guided axillary node core biopsy in staging of early breast cancerP D Britton, A Goud, S Godward, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2015
PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytesH R Ali, S-E Glont, F M Blows, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 12, 2025
Discrepancy between mammographic and pathological sizing of screen-detected DCIS: Risk factors and impact on ipsilateral recurrence ratesC C Kirwan, B Hilton, K Clements, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2015
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaborationV Bossuyt, E Provenzano, W F Symmans, et al.
British Journal of Cancer|July 29, 2010
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy receivedS-J Dawson, N Makretsov, F M Blows, et al.
Pageof 4